Visium Technolog Financials
This page shows Visium Technolog (VISM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Balance-sheet survival dominates: liabilities dwarf assets and repeated share issuance has not rebuilt the company’s liquidity cushion.
From FY2023 to FY2025, cash improved from$10K to$60K , but current liabilities also climbed from$4.3M to$5.9M ; the balance sheet gained dollars without gaining real flexibility, because the liquid buffer stayed tiny against near-term claims.
The more striking shift is in capital structure: shares outstanding expanded from 2.2M in FY2021 to 368.5M in FY2025 while cash never reached
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Visium Technolog's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Visium Technolog's current ratio of 0.01 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Key Financial Metrics
Earnings & Revenue
Visium Technolog generated $0 in revenue in fiscal year 2025.
Visium Technolog earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Cash & Balance Sheet
Visium Technolog held $60K in cash against $0 in long-term debt as of fiscal year 2025.
Visium Technolog had 369M shares outstanding in fiscal year 2025. This represents an increase of 72.3% from the prior year.
Margins & Returns
Capital Allocation
Visium Technolog invested $325 in research and development in fiscal year 2025.
VISM Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $0 | N/A | N/A | $0-100.0% | $75 | $0 | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | $83K | N/A | N/A | $98K | N/A | N/A | N/A |
| Income Tax | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A |
VISM Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13K-54.6% | $28K+220.8% | $9K-87.3% | $68K+204.6% | $22K+233.7% | $7K-17.9% | $8K-4.2% | $8K |
| Current Assets | $13K-54.6% | $28K+220.8% | $9K-87.3% | $68K | N/A | $7K-17.9% | $8K-4.2% | $8K |
| Cash & Equivalents | $665-97.2% | $24K+699.6% | $3K-95.0% | $60K+170.8% | $22K+233.7% | $7K-17.9% | $8K-4.2% | $8K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $6.8M+6.6% | $6.4M+6.1% | $6.0M+2.4% | $5.9M+11.3% | $5.3M+6.3% | $5.0M+6.0% | $4.7M-8.7% | $5.2M |
| Current Liabilities | $6.8M+6.6% | $6.4M+6.1% | $6.0M+2.4% | $5.9M+11.3% | $5.3M+6.3% | $5.0M+6.0% | $4.7M-8.7% | $5.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$6.8M-6.9% | -$6.4M-5.8% | -$6.0M-3.4% | -$5.8M-10.5% | -$5.3M-6.0% | -$5.0M-6.1% | -$4.7M+8.7% | -$5.1M |
| Retained Earnings | -$65.6M-0.9% | -$65.0M-0.8% | -$64.5M-0.7% | -$64.1M-1.5% | -$63.2M-0.6% | -$62.8M-0.6% | -$62.4M+0.5% | -$62.7M |
VISM Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | -$129K | N/A | -$157K-341.3% | -$36K | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $54K | N/A | N/A | $195K+281.3% | $51K | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
VISM Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.000.0 | 0.000.0 | 0.00-0.0 | 0.01 | N/A | 0.000.0 | 0.000.0 | 0.00 |
| Debt-to-Equity | -1.000.0 | -1.000.0 | -1.00+0.0 | -1.010.0 | -1.000.0 | -1.000.0 | -1.000.0 | -1.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$5.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Visium Technolog's annual revenue?
Visium Technolog (VISM) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What are Visium Technolog's total assets?
Visium Technolog (VISM) had $68K in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Visium Technolog spend on research and development?
Visium Technolog (VISM) invested $325 in research and development during fiscal year 2025.
What is Visium Technolog's current ratio?
Visium Technolog (VISM) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Visium Technolog's debt-to-equity ratio?
Visium Technolog (VISM) had a debt-to-equity ratio of -1.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
Why is Visium Technolog's debt-to-equity ratio negative or unusual?
Visium Technolog (VISM) has negative shareholder equity of -$5.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
How financially healthy is Visium Technolog?
Visium Technolog (VISM) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.